NF-κB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach
- 24 December 2002
- journal article
- review article
- Published by Elsevier in Seminars in Cancer Biology
- Vol. 13 (1) , 15-28
- https://doi.org/10.1016/s1044-579x(02)00096-2
Abstract
No abstract availableKeywords
This publication has 177 references indexed in Scilit:
- Increased and correlated nuclear factor-kappa B and Ku autoantigen activities are associated with development of multidrug resistanceOncogene, 2001
- MAIL, a novel nuclear IκB protein that potentiates LPS‐induced IL‐6 productionFEBS Letters, 2000
- Activation of the IκB Kinase Complex by TRAF6 Requires a Dimeric Ubiquitin-Conjugating Enzyme Complex and a Unique Polyubiquitin ChainPublished by Elsevier ,2000
- PKC-θ is required for TCR-induced NF-κB activation in mature but not immature T lymphocytesNature, 2000
- Activators and target genes of Rel/NF-κB transcription factorsOncogene, 1999
- Nuclear Factor κB Activity Is Essential for Matrix Metalloproteinase-1 and -3 Upregulation in Rabbit Dermal FibroblastsBiochemical and Biophysical Research Communications, 1999
- Suppression of TNF?-mediated NF?b activity by myricetin and other flavonoids through downregulating the activity of IKK in ECV304 cellsJournal of Cellular Biochemistry, 1999
- The F-box protein β-TrCP associates with phosphorylated β-catenin and regulates its activity in the cellPublished by Elsevier ,1999
- NF-κB activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1αProceedings of the National Academy of Sciences, 1998
- Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3βPublished by Elsevier ,1998